In this case series study, the investigators are testing the hypothesis that sublingual sufentanil (Dsuvia) will improve postoperative pain management in the Post Anesthesia Care Unit (PACU) in ambulatory surgery patients taking Suboxone.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
3
Subject will receive up to 2 doses of Dsuvia. The first dose will be intra-op and the second dose will be post-op (if needed)
Montefiore Medical Center
The Bronx, New York, United States
Morphine Equivalence
Evaluate the total amount of morphine equivalence (MME) in the perioperative period (defined as combined total opioid used intra-op and in the PACU).
Time frame: During day of surgery
Time to Fit to Discharge From the PACU (Post-Anesthesia Care Unit)
How much time did subject take to become considered 'fit to discharge?'
Time frame: During stay in PACU, up until discharge from PACU
Need for Additional Opioids Following Surgery
A measure of how any additional opioids subjects were administered
Time frame: PACU stay to 24 hours post hospital discharge
Time to Take the First Additional Opioid
Average time for administration of first additional opioid.
Time frame: 24 hours post hospital discharge
Adverse Events in the PACU
Make note of nausea, vomiting, itching, hypotension, dizziness that occur while in PACU
Time frame: During PACU stay, up until discharge from PACU
Adverse Events Post Discharge From PACU
Make note of nausea, vomiting, itching, hypotension, dizziness that occur within 24 hours after being discharged from PACU
Time frame: 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.